Physician Assistant · Independent exam preparation
Traditional PANRE: Core Clinical Decisions Study Guide
Practise urgent triage, diagnostic confirmation, treatment, and monitoring across PANRE domains with 60 focused concepts, 20 questions, and 20 recall cards.
By CertMedbry · Updated 14 October 2026
Recognise dangerous presentations, choose tests that resolve diagnostic uncertainty, and connect treatment and monitoring to disease mechanisms. This selective guide develops 60 clinical decisions across every domain of NCCPA's PANRE/PANRE-LA blueprint, effective January 2023. The complete official outline remains the full examination scope; the selected topics here do not replace it. Domain emphasis approximately follows the published weights, but the selected diseases represent only part of each domain. The outline specifies History & Physical, Diagnosis, Intervention (Basic), and Intervention (Complex) expectations. Hypothyroidism, diabetes, stroke, and CKD include both intervention levels; the decisions here therefore address straightforward treatment, monitoring, and selected complications as well as diagnosis.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which recertification pathway does this guide target?
The guide targets traditional, proctored PANRE. NCCPA's PANRE-LA fact sheet confirms that traditional PANRE remains available to PAs choosing that format and to those who do not successfully complete PANRE-LA. The clinical blueprint applies to both pathways, but their administration differs.
Which blueprint and effective date apply?
The official NCCPA Content Blueprint for PANRE and PANRE-LA is effective beginning January 2023. It describes core medical knowledge across PA specialties and practice settings, informed by the 2021 practice analysis. The fact sheet's 2025 publication date is separate from the blueprint's effective date.
NCCPA Content Blueprint for PANRE and PANRE-LA · NCCPA PANRE Longitudinal Assessment Fact Sheet
How is traditional PANRE delivered, and how can candidates practise the computer interface?
Traditional PANRE is a proctored computer examination at Pearson VUE test centers. Pearson VUE's NCCPA tutorial lets candidates practise navigating questions, changing answers, marking questions for review, and accessing laboratory values. Apply and pay through NCCPA and receive the examination acknowledgement before scheduling the appointment with Pearson VUE.
NCCPA PANRE Longitudinal Assessment Fact Sheet · National Commission on Certification of Physician Assistants Certification Testing
What are the question count, block timing, testing duration, and breaks?
Traditional PANRE contains 240 multiple-choice questions in four blocks of 60, with 60 minutes per block. The five-hour schedule includes four hours of testing, 45 minutes of breaks between blocks, and a 15-minute tutorial. PANRE includes scored and unscored pretest questions; candidates cannot distinguish them. See [NCCPA PANRE information](https://www.nccpa.net/maintain-certification/), [test-day information](https://www.nccpa.net/become-certified/test-day/), and [exam development and scoring](https://www.nccpa.net/examdevelopmentscoring/).
NCCPA PANRE Longitudinal Assessment Fact Sheet · National Commission on Certification of Physician Assistants Certification Testing
What characteristics do these practice questions have?
These are original educational practice questions with four options and one best answer. Their clinical vignettes ask learners to recognise presentations, interpret results, and select appropriate investigations or actions. Each explanation discusses the correct option and all three alternatives. These independently authored questions are not official NCCPA examination items.
PANRE-PANRELA-2023CB20230224.pdf · NCCPA PANRE Longitudinal Assessment Fact Sheet
How should the official domain weights guide preparation?
The blueprint allocates Cardiovascular 12%; Dermatologic 5%; Endocrine 8%; Eyes, Ears, Nose, and Throat 8%; Gastrointestinal/Nutrition 10%; Genitourinary 5%; Hematologic 4%; Infectious Diseases 7%; Musculoskeletal 8%; Neurologic 5%; Psychiatry/Behavioral Science 7%; Pulmonary 10%; Renal 4%; Reproductive 5%; and Emergent Topics 2%. NCCPA notes that percentages may vary slightly. This guide approximates those allocations while representing every domain. Preparation should also follow each disease row's performance expectations, including treatment and complications where intervention is specified.
How do PANRE, PANCE, PANRE-LA, and specialty CAQs differ?
PANCE is the initial NCCPA certification examination. Traditional PANRE and PANRE-LA are recertification pathways for maintaining certification. A specialty CAQ provides additional recognition and has separate requirements; it is not another name for PANRE. NCCPA certification also remains distinct from jurisdiction-specific PA licensure or regulation.
National Commission on Certification of Physician Assistants Certification Testing · NCCPA PANRE Longitudinal Assessment Fact Sheet
This independent guide targets traditional PANRE for physician assistants maintaining NCCPA certification in the United States. PANRE is distinct from initial-certification PANCE and specialty Certificate of Added Qualifications examinations. PANRE-LA is a separate longitudinal recertification alternative that shares the content blueprint. The original learning questions are educational drills and do not predict examination performance.
Outline used: NCCPA PANRE/PANRE-LA Content Blueprint, effective January 2023; full 14-page official blueprint opened and inspected on 2026-10-09.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Cardiovascular System12%
1.What makes chest pain suggest acute pericarditis?
Inflammation of the pericardial layers can produce sharp chest pain that worsens with deep inspiration or lying flat and improves when sitting forward. A friction rub supports the diagnosis because inflamed surfaces move against one another. These features help distinguish pericardial pain from other chest-pain mechanisms, but they do not independently exclude myocardial ischemia or pulmonary embolism. Evaluate the whole presentation, including vital signs, examination, ECG, and evidence of complications.
Apply it
A patient develops sharp chest pain after a viral illness. It worsens while supine and eases when leaning forward. Use the positional pattern and friction rub to support pericarditis while assessing competing urgent diagnoses.
Common pitfall: Calling every pleuritic pain pericarditis overlooks pulmonary and vascular causes. A characteristic position-related pattern supports a diagnosis but does not replace assessment for instability.
2.How does pericardial effusion become cardiac tamponade?
A pericardial effusion is fluid accumulation around the heart; tamponade occurs when pressure from that fluid impairs cardiac filling and reduces output. The physiological effect depends on accumulation rate and pericardial accommodation, not simply fluid volume. New hypotension, dyspnea, or worsening circulatory compromise in someone with an effusion raises concern for tamponade. Echocardiography evaluates the fluid and its cardiac effects, while an unstable patient requires urgent management rather than routine surveillance.
Apply it
A patient with a known effusion becomes breathless, tachycardic, and hypotensive. Treat the new hemodynamic change as possible impaired cardiac filling and arrange immediate emergency assessment with echocardiographic evaluation, rather than a routine follow-up visit.
Common pitfall: Equating any effusion with tamponade overstates severity. Conversely, a modest effusion can be dangerous when pressure rises quickly and circulation begins to deteriorate.
3.Why does aortic stenosis create a pressure burden?
A stenotic aortic valve narrows the outlet through which the left ventricle ejects blood. The ventricle must generate greater pressure to maintain forward flow, creating a pressure burden rather than a primary backward-flow problem. Progressive obstruction can limit output, particularly during exertion. A compatible murmur or exertional symptoms should lead to echocardiographic assessment of valve opening, flow, and ventricular function; the murmur alone does not establish the degree of obstruction.
Apply it
An older adult reports exertional dizziness and breathlessness, and examination suggests an aortic valve murmur. Connect the symptoms to restricted forward flow and obtain echocardiographic assessment instead of estimating severity solely from auscultation.
Common pitfall: Describing stenosis as blood leaking backward confuses obstruction with regurgitation. Both can cause symptoms, but their flow abnormalities and ventricular burdens differ substantially.
NHLBI: Heart Valve Diseases—Types · NHLBI: Heart Valve Diseases—Diagnosis
4.How does valve regurgitation produce volume loading?
Regurgitation occurs when a valve fails to close completely, allowing blood to flow backward during the phase when the valve should be closed. The receiving chamber must accommodate additional blood, creating volume loading and potentially chamber enlargement or impaired function. The key distinction from stenosis is leakage rather than restricted opening. Echocardiography identifies the affected valve and assesses the backward flow, chamber response, and functional consequences instead of treating every murmur as the same lesion.
Apply it
An echocardiogram shows incomplete mitral valve closure with backward flow into the left atrium during ventricular contraction. Explain the finding as regurgitation and consider the added volume burden when interpreting chamber size and symptoms.
Common pitfall: A murmur identifies abnormal flow, not necessarily obstruction. Assuming that all valve disease imposes the same burden obscures the distinction between pressure and volume loading.
NHLBI: Heart Valve Diseases—Types · NHLBI: Heart Valve Diseases—Diagnosis
5.Which test characterises suspected structural valve disease?
Echocardiography uses ultrasound to show valve structure, chamber size, and cardiac movement. Doppler techniques assess blood-flow direction and velocity, helping characterise stenosis or regurgitation. This makes echocardiography the central structural and flow assessment when examination suggests valve disease. An ECG provides electrical information, and ambulatory monitoring samples rhythm over time; neither substitutes for visualising valve function. Match the investigation to the clinical uncertainty rather than choosing a familiar cardiac test automatically.
Apply it
A patient has a new murmur with reduced exercise tolerance. The unanswered question concerns valve anatomy and blood flow. Choose transthoracic echocardiography with Doppler rather than ambulatory rhythm monitoring as the initial targeted investigation.
Common pitfall: A normal ECG does not exclude a structural valve lesion. Electrical testing and ultrasound answer different questions and should not be treated as interchangeable investigations.
6.How is atrial fibrillation confirmed?
Atrial fibrillation has irregular R–R intervals when atrioventricular conduction is present, no distinct P waves, and irregular fibrillatory atrial activity. An irregular pulse raises suspicion but cannot identify the rhythm alone. Other irregular rhythms, such as sinus rhythm with premature beats or multifocal atrial tachycardia, retain discernible P waves. A clinician must visually interpret the ECG or rhythm recording to confirm atrial fibrillation rather than accepting an automated label alone. Intermittent episodes may require longer monitoring. See the [ACC/AHA/ACCP/HRS atrial fibrillation guideline](https://www.ahajournals.org/doi/10.1161/CIR.0000000000001193?url_ver=Z39.88-2003).
Apply it
A patient reports palpitations and has an irregular pulse. Visually examine the ECG for irregular R–R intervals, absent distinct P waves, and fibrillatory atrial activity; identifiable P waves should prompt consideration of another irregular rhythm.
Common pitfall: Irregularity alone is insufficient. An automated device notification requires visual confirmation, and a normal recording between episodes cannot reliably exclude intermittent atrial fibrillation.
7.When is ambulatory rhythm monitoring more useful than a resting ECG?
A resting ECG samples a short interval, so it may miss a rhythm disturbance that occurs away from the examination. Ambulatory monitoring extends the observation window and can connect symptoms with recorded electrical activity. Select the recording approach according to how often symptoms occur and whether continuous or event-triggered capture is needed. Frequent episodes suit shorter continuous observation better than rare events; an infrequent symptom requires a sufficiently long opportunity for capture.
Apply it
A patient experiences brief palpitations several times a month, but the clinic ECG is normal. Arrange monitoring with a recording window suited to infrequent events and ask the patient to document symptoms for correlation.
Common pitfall: Repeating brief resting ECGs may keep missing the same intermittent problem. Monitoring duration should reflect symptom frequency rather than an arbitrary delay before further investigation.
Dermatologic System5%
8.Which organisms guide treatment of typical nonpurulent cellulitis?
Typical cellulitis without an abscess or purulent drainage is usually managed with antimicrobial activity against streptococci. Purulence, penetrating trauma, known MRSA risk, and systemic severity can change the required coverage. The initial distinction is therefore nonpurulent infection versus a purulent collection, followed by severity and risk assessment. Broadening every uncomplicated case to extensive MRSA or gram-negative coverage adds treatment burden without addressing the usual mechanism more precisely.
Apply it
An otherwise stable adult has unilateral spreading leg erythema and tenderness without drainage, fluctuance, or MRSA risk factors. Select streptococcal coverage and assess the skin for an entry site rather than automatically prescribing broad combination therapy.
Common pitfall: Using purulent-infection coverage for every red leg ignores the distinction between cellulitis and abscess. Also consider noninfectious mimics when the presentation is atypical.
9.Why does a skin abscess require source control?
An abscess is a localised collection of pus, so treatment must address the collection itself. Incision and drainage provide source control and are central for an accessible cutaneous abscess. Antibiotic decisions depend on systemic illness, host factors, and other severity considerations; antibiotics do not make drainage unnecessary. Fluctuance or a demonstrated collection changes management from treating diffuse cellulitis alone to evacuating infected material while assessing whether additional antimicrobial therapy is indicated.
Apply it
A patient has a tender, fluctuant skin lesion with surrounding redness. Recognise a drainable collection and arrange incision and drainage, then use the patient's systemic findings and host risks to decide whether antibiotics are also needed.
Common pitfall: Treating an abscess with antibiotics alone leaves the collection in place. Conversely, adjunctive antibiotics should follow severity and host assessment rather than a universal rule.
10.How can recurrent lower-extremity cellulitis be prevented?
Repeated cellulitis often reflects persistent local vulnerabilities such as edema, venous disease, eczema, or disrupted skin between the toes. Prevention includes managing swelling and skin disease and treating interdigital fissuring or maceration that permits bacterial entry. IDSA recommends considering prophylactic antibiotics when a patient has three to four cellulitis episodes per year despite attempts to treat or control predisposing factors. Prophylaxis supplements continued edema, skin-barrier, and interdigital care; it does not replace them.
Apply it
A patient has four leg-cellulitis episodes in a year despite edema management and treatment of cracked toe webs. Review prophylactic antibiotic options while continuing measures that control swelling and protect the skin barrier.
Common pitfall: Repeated acute antibiotic courses leave persistent entry sites unresolved. Prophylaxis should not substitute for risk-factor management or be started solely because one episode recurred.
Endocrine System8%
11.How do TSH and free T4 identify primary hypothyroidism?
When the thyroid gland produces insufficient hormone, the pituitary normally responds by increasing TSH. Elevated TSH with low free T4 therefore supports overt primary hypothyroidism. Elevated TSH with free T4 still within range describes a different biochemical state and should not be labelled overt disease automatically. Symptoms such as fatigue or cold intolerance are compatible but nonspecific. Interpret the paired results, clinical context, medications, and relevant laboratory ranges rather than diagnosing from symptoms alone.
Apply it
A patient with constipation and cold intolerance has elevated TSH and low free T4. Recognise overt primary hypothyroidism because the pituitary signal is increased while circulating thyroid hormone is reduced, rather than attributing symptoms to fatigue alone.
Common pitfall: TSH alone does not describe every thyroid disorder. A low free T4 without an appropriately elevated TSH requires consideration of a different regulatory problem.
12.How do cause, hormone replacement, and monitoring fit together in hypothyroidism?
Thyroid antibodies support an autoimmune cause such as Hashimoto disease; TSH and free T4 establish current function. Antibody positivity alone does not establish overt deficiency or a treatment requirement. Established hypothyroidism is treated with levothyroxine to replace missing thyroid hormone. Recheck thyroid blood tests about 6–8 weeks after starting treatment and after dose adjustments; once stable, reassess at about six months and then annually. Excess replacement can cause atrial fibrillation or osteoporosis. Pregnancy often increases replacement needs and calls for prompt reassessment. Severe untreated disease can progress to myxedema coma, which requires immediate treatment.
Apply it
A patient with overt autoimmune hypothyroidism starts levothyroxine. Arrange reassessment in 6–8 weeks and adjust using thyroid function results. If pregnancy occurs, review replacement promptly rather than leaving the previous dose unexamined.
Common pitfall: Antibodies identify cause rather than replacement needs. Persistent fatigue alone does not justify increasing levothyroxine without biochemical reassessment; excessive replacement has cardiac and skeletal risks.
NIDDK: Thyroid Tests · NIDDK: Hypothyroidism · PANRE-PANRELA-2023CB20230224.pdf
13.Which laboratory thresholds support a diabetes diagnosis?
Diabetes-range laboratory results include A1C at least 6.5%, fasting plasma glucose at least 126 mg/dL, or two-hour plasma glucose at least 200 mg/dL during a standard oral glucose tolerance test. Random plasma glucose at least 200 mg/dL with classic hyperglycemic symptoms can also establish the diagnosis. In an asymptomatic person, confirmation is generally required. A home glucose meter can prompt evaluation but should not substitute for appropriate laboratory diagnostic testing.
Apply it
An asymptomatic adult has a laboratory fasting plasma glucose of 131 mg/dL. Recognise a diabetes-range result and arrange confirmation rather than diagnosing from one screening value or dismissing it because the patient feels well.
Common pitfall: Confusing a diagnostic threshold with a daily treatment target leads to misclassification. Home meter values and unconfirmed asymptomatic screening results require appropriate laboratory evaluation.
NIDDK: Diabetes Tests and Diagnosis · NIDDK: Diabetes and Prediabetes Tests
14.How should discordant diabetes tests be confirmed?
Different diabetes tests measure related but nonidentical aspects of glycemia, so their classifications may disagree. When an asymptomatic patient's tests are discordant, promptly repeat the test that exceeded the diagnostic threshold and consider factors that could distort its result. Confirmation is based on the repeat abnormal test rather than averaging unlike measurements or waiting for symptoms. If repeat laboratory A1C remains in the diabetes range and is reliable, a lower fasting glucose does not negate it.
Apply it
An asymptomatic patient has laboratory A1C of 6.7% and fasting plasma glucose of 118 mg/dL, with no known A1C interference. Repeat the A1C promptly to determine whether the diabetes-range result is confirmed.
Common pitfall: Averaging A1C and fasting glucose is meaningless because they use different scales. Waiting for symptomatic hyperglycemia unnecessarily delays clarification of a potentially diagnostic result.
15.How should A1C reliability and hypoglycemia risk guide diabetes treatment monitoring?
A1C reflects glucose exposure of hemoglobin over circulating red-cell lifespans. Altered red-cell survival, recent blood loss or transfusion, and some hemoglobin variants can distort it; suitable plasma glucose assessment helps resolve substantial discrepancies. For established diabetes, measure A1C at least twice yearly and more often when goals are unmet. A target below 7% benefits many patients, but severe hypoglycemia, hypoglycemia unawareness, limited life expectancy, or advanced complications can justify a less stringent target. Review and modify treatment when its glucose-lowering burden causes recurrent hypoglycemia rather than pursuing a lower A1C at any cost.
Apply it
A patient with advanced CKD has recurrent hypoglycemia despite an A1C below 7%. Review the glucose-lowering regimen and choose a safer individual target. After transfusion, use suitable glucose measurements rather than escalating treatment from a potentially misleading A1C.
Common pitfall: A1C does not reveal every acute glucose excursion or prove treatment safety. A low average can coexist with dangerous hypoglycemia, and hematologic interference can misdirect treatment changes.
NIDDK: Diabetes Tests and Diagnosis · The A1C Test & Diabetes - NIDDK · PANRE-PANRELA-2023CB20230224.pdf
28.How does CKD change treatment selection and precautions in type 2 diabetes?
KDIGO recommends an SGLT2 inhibitor for type 2 diabetes with CKD when eGFR is at least 20 mL/min/1.73 m². This adds kidney protection to the treatment strategy. The reversible initial eGFR decrease generally does not require discontinuation. Temporarily withhold the drug during prolonged fasting, surgery, or critical illness because ketosis risk increases. These decisions connect uncomplicated treatment selection with management when illness changes medication safety.
Apply it
An adult with type 2 diabetes and CKD has eGFR of 38 mL/min/1.73 m². Include an appropriate SGLT2 inhibitor in treatment planning and explain temporary withholding during surgery or critical illness.
Common pitfall: Do not equate every initial eGFR decrease with progressive kidney injury or continue the drug uncritically during prolonged fasting.
Executive Summary of the KDIGO 2024 CKD Guideline · PANRE-PANRELA-2023CB20230224.pdf
Eyes, Ears, Nose, and Throat8%
16.What causes positional vertigo in BPPV?
Benign paroxysmal positional vertigo occurs when displaced otoconia enter a semicircular canal and create an inappropriate motion signal during certain head movements. The resulting brief spinning attacks are position-triggered because the particles move with gravity, often when rolling in bed or looking upward. This mechanical explanation connects the characteristic symptom pattern to repositioning treatment. Continuous vertigo, near-syncope on standing, or new neurologic abnormalities requires a broader assessment.
Apply it
A patient feels brief spinning when rolling toward one side in bed but feels substantially better while still. Connect the attacks to gravity-sensitive particle movement within a semicircular canal and assess for a compatible positional response.
Common pitfall: Head movement can worsen many vestibular disorders. A reproducible brief attack triggered by position is more specific than general movement intolerance, and antibiotics do not correct displaced otoconia.
AAO-HNSF: Frequently Asked Questions—Benign Paroxysmal Positional Vertigo
17.Which presentation suggests acute angle-closure glaucoma?
Sudden intense eye pain, a red eye, blurred vision, and nausea suggest acute angle-closure glaucoma. The iris blocks the drainage opening where the iris and cornea meet, allowing intraocular fluid and pressure to accumulate and threaten the optic nerve. This pattern requires immediate ophthalmic or emergency assessment rather than routine follow-up for eye irritation. See [NEI glaucoma information](https://www.nei.nih.gov/eye-health-information/eye-conditions-and-diseases/glaucoma) and [eye-pressure physiology](https://www.nei.nih.gov/eye-health-information/eye-conditions-and-diseases/glaucoma/glaucoma-and-eye-pressure).
Apply it
A patient has sudden painful red-eye symptoms with blurred vision and nausea. Recognise a possible pressure-related ocular emergency and arrange immediate assessment.
Common pitfall: Nausea does not make this primarily a gastrointestinal illness. Severe eye pain with visual change should prevent routine treatment as uncomplicated conjunctivitis.
18.How does positional examination clarify suspected BPPV?
The Dix–Hallpike maneuver assesses posterior-canal BPPV by changing head position and observing the response. Provoked vertigo with torsional, upbeating nystagmus supports posterior-canal disease. Test the other side when the initial maneuver is negative. When the history remains compatible but Dix–Hallpike produces horizontal or no nystagmus, perform or arrange a supine roll test to assess lateral-canal BPPV. Canal identification guides the appropriate repositioning maneuver. See the [AAO-HNSF BPPV guideline](https://journals.sagepub.com/doi/full/10.1177/0194599816689667).
Apply it
A patient has brief vertigo when lying back. Torsional, upbeating nystagmus during Dix–Hallpike supports posterior-canal BPPV; a horizontal response or no nystagmus with a compatible history calls for supine roll testing.
Common pitfall: Dizziness during positioning alone is insufficient. Horizontal nystagmus should not be labelled the characteristic posterior-canal response, and a negative Dix–Hallpike does not exclude lateral-canal disease.
AAO-HNSF: Frequently Asked Questions—Benign Paroxysmal Positional Vertigo
19.Why are canalith repositioning maneuvers effective?
Canalith repositioning uses a sequence of head and body positions to move displaced otoconia out of the affected semicircular canal. It addresses the mechanical source of false motion signals rather than merely suppressing the sensation of dizziness. The maneuver should match the assessed canal and account for the patient's ability to tolerate positioning. Symptom-suppressing medication may change how a patient feels, but it does not physically relocate the particles causing typical BPPV.
Apply it
A patient with confirmed positional vertigo asks for medication to remove the cause. Explain how an appropriate repositioning maneuver moves the particles and assess whether neck or mobility limitations require a modified approach or specialist assistance.
Common pitfall: Symptom relief from medication does not demonstrate that the mechanical problem has resolved. Repositioning and symptom suppression have different purposes and should not be confused.
AAO-HNSF: Frequently Asked Questions—Benign Paroxysmal Positional Vertigo
20.Which visual symptoms require urgent assessment for retinal detachment?
A sudden increase in floaters, flashes of light, or a shadow resembling a curtain across the visual field can indicate a retinal tear or detachment. Detachment separates the retina from its normal position and can cause permanent vision loss. Arrange immediate eye-care or emergency assessment; a dilated retinal examination evaluates the suspected lesion, with ocular ultrasound or OCT used when additional information is needed. See [NEI retinal detachment information](https://www.nei.nih.gov/eye-health-information/eye-conditions-and-diseases/retinal-detachment).
Apply it
A patient reports new flashes and numerous floaters followed by a dark curtain in one eye. Arrange immediate retinal assessment rather than waiting for a routine eye appointment.
Common pitfall: Longstanding stable floaters and a sudden change carry different implications. New floaters with flashes or a field shadow require urgent evaluation even before extensive vision loss occurs.
Gastrointestinal System and/or Nutrition10%
21.Why should gluten remain in the diet during celiac testing?
Celiac disease testing looks for immune responses and intestinal injury associated with gluten exposure. Starting a gluten-free diet before evaluation can reduce those abnormalities and make blood tests or biopsies falsely reassuring. A patient who is still eating gluten should generally complete diagnostic evaluation before eliminating it. For someone already avoiding gluten, document the dietary history and plan an appropriate diagnostic approach; a negative test under reduced exposure does not have the same meaning as a negative test during exposure.
Apply it
A patient with chronic diarrhea plans to stop gluten before scheduled celiac testing. Explain that dietary elimination may obscure the diagnostic evidence and coordinate testing while the patient is still consuming gluten, when clinically appropriate.
Common pitfall: Improvement after avoiding gluten does not independently prove celiac disease. Starting elimination before testing can make later confirmation more difficult and reduce test sensitivity.
22.How does IgA deficiency affect celiac serology?
Common celiac screening tests measure IgA antibodies, particularly tissue transglutaminase IgA. A patient with deficient total IgA may therefore have a negative IgA-based result despite disease. Measuring total IgA helps interpret the screening result, and suitable IgG-based tests can be used when IgA deficiency is present. The key principle is to distinguish absence of the target antibody response from inability to produce the antibody class that the assay is designed to detect.
Apply it
A patient with malabsorptive symptoms has negative tissue transglutaminase IgA but very low total IgA. Use an appropriate IgG-based celiac assessment rather than treating the negative IgA assay as a reliable exclusion of disease.
Common pitfall: A negative antibody test is not equally informative in every patient. Ignoring total IgA can convert a predictable assay limitation into a missed diagnosis.
23.What can celiac genetic testing establish?
Celiac-associated HLA variants indicate genetic susceptibility, but many people carrying them never develop celiac disease. Their presence therefore does not confirm active disease. Absence of the relevant variants makes celiac disease very unlikely and can help resolve selected uncertain cases, including those already avoiding gluten. Genetic testing answers a susceptibility question; antibody testing and intestinal assessment address immune activity and injury. Keep these roles separate when explaining a positive result to a patient.
Apply it
A patient following a gluten-free diet has a positive celiac-associated HLA result and assumes the diagnosis is confirmed. Explain that the result permits the possibility of disease but does not demonstrate current gluten-related intestinal injury.
Common pitfall: A susceptibility marker is not a disease diagnosis. Positive HLA testing is much less specific for active celiac disease than patients often assume.
24.How does small-intestinal biopsy contribute to celiac diagnosis?
An upper gastrointestinal endoscopy can obtain small-intestinal tissue to evaluate the mucosal injury associated with celiac disease. Biopsy adds structural evidence to serologic and clinical findings and is commonly used to confirm the diagnosis. Interpretation depends on adequate sampling and gluten exposure, because injury may diminish after dietary elimination. A positive screening antibody is a reason to complete appropriate evaluation, not a reason to assume that every gastrointestinal symptom has already been explained.
Apply it
An adult eating gluten has positive celiac serology and persistent diarrhea. Arrange appropriate confirmatory evaluation, including small-intestinal biopsy when indicated, and explain that the tissue assessment examines injury rather than merely repeating an antibody measurement.
Common pitfall: Treating a screening result as the whole diagnostic process may misclassify disease. Conversely, a biopsy after prolonged gluten avoidance may underestimate prior intestinal injury.
25.How do symptoms and laboratory findings support appendicitis assessment?
Appendicitis assessment combines the pain history, abdominal examination, laboratory findings, and imaging when needed. Pain that begins centrally and later localises to the right lower abdomen is suggestive, but not every patient follows that pattern. Blood tests may show inflammation and urine testing can investigate alternatives, yet neither a normal inflammatory result nor an isolated abnormal value settles the diagnosis. Serial clinical assessment matters when early findings are incomplete or the presentation is atypical.
Apply it
A patient has evolving right lower abdominal pain and tenderness despite a normal initial white-cell count. Continue the appendicitis evaluation using the clinical course and appropriate imaging rather than dismissing the diagnosis from one laboratory result.
Common pitfall: A normal white-cell count does not reliably exclude appendicitis. Laboratory findings support the assessment but cannot replace the pain trajectory, examination, and appropriate imaging.
26.How does clinical risk determine pediatric appendicitis imaging?
Clinical risk assessment determines whether imaging is needed. Low-risk children commonly undergo clinical observation and reassessment rather than immediate imaging; ACR rates initial imaging as usually not appropriate in that group. For an intermediate-risk child requiring imaging, abdominal or right lower quadrant ultrasound is usually appropriate and avoids ionising radiation. Nonvisualisation of the appendix alone does not exclude appendicitis. After nondiagnostic ultrasound, reassess the examination and clinical trajectory. Persistent concern can warrant MRI or CT of the abdomen and pelvis with IV contrast, selected according to availability, feasibility, and suspected complications.
Apply it
A stable child is assessed as intermediate risk and needs imaging. Obtain ultrasound. If it is nondiagnostic and tenderness or other concerning findings persist, continue evaluation with MRI or contrast-enhanced CT as appropriate. A low-risk child may instead need observation and reassessment.
Common pitfall: Stability alone does not establish an imaging indication. An inconclusive ultrasound is not automatic exclusion, but nonvisualisation alone also does not mandate immediate CT in every child.
Genitourinary System5%
27.Why is suspected testicular torsion time critical?
Testicular torsion twists the spermatic cord and threatens the testicle's blood supply. Sudden severe testicular pain therefore requires emergency assessment, particularly when accompanied by nausea, vomiting, or abdominal pain. The priority is rapid evaluation of a potentially ischemic testicle rather than routine outpatient treatment for a presumed infection. A patient should not wait for the pain to become prolonged or for every classic examination feature to appear before seeking urgent care. Absence of visible swelling does not make this emergency pattern harmless.
Apply it
An adolescent develops abrupt severe unilateral testicular pain with vomiting during sports. Arrange immediate emergency evaluation for possible torsion even without obvious swelling, recognising that a vascular threat must be addressed before a routine outpatient explanation is accepted.
Common pitfall: Age or presumed activity-related strain cannot safely dismiss sudden severe scrotal pain. Waiting for swelling or spontaneous improvement may delay assessment of a threatened testicular blood supply.
29.How should pain and painless scrotal changes be assessed differently?
Acute severe testicular pain raises an immediate concern for torsion, whereas a painless lump, swelling, or change in testicular shape requires a separate clinical assessment. Possible causes of scrotal symptoms include infection, cysts, fluid collections, hernia, and other conditions; patients should not self-diagnose from appearance alone. The useful decision is the level of urgency and need for examination. A painless change is not equivalent to an ischemic emergency, but it should not be ignored.
Apply it
One patient reports abrupt severe pain with vomiting; another notices a painless testicular lump. Direct the first to emergency evaluation and arrange clinical assessment of the second, explaining that different presentations require different urgency and diagnostic consideration.
Common pitfall: Assuming every scrotal symptom is torsion creates imprecise triage. Assuming a painless lump is harmless is also unsafe; it still requires examination and assessment.
Hematologic System4%
30.Which ferritin criteria support iron deficiency, and how does inflammation change testing?
Ferritin reflects stored iron; depleted stores limit hemoglobin production and can cause anemia. ASH suggests ferritin at or below 30 ng/mL for diagnosing iron deficiency in the general adult population, excluding menstruating or pregnant individuals from that particular population statement. Separate ASH recommendations also use at or below 30 ng/mL in menstruating and pregnant individuals. For general adults with compatible symptoms or ongoing risk factors, a threshold at or below 50 ng/mL may be appropriate. These are clinical decision thresholds, regardless of a laboratory's normal range. In adults with anemia of inflammation, assess both ferritin and transferrin saturation because inflammation can elevate ferritin; disease-specific interpretation remains necessary.
Apply it
A nonpregnant, nonmenstruating adult has ferritin of 26 ng/mL, although the laboratory reports a lower limit of 15. Recognise that the result meets ASH's suggested adult deficiency threshold. In an anemic patient with inflammation and higher ferritin, obtain transferrin saturation as well.
Common pitfall: A laboratory reference interval is not a diagnostic decision threshold. Microcytosis alone does not establish iron deficiency, and inflammation can make ferritin alone falsely reassuring.
31.Why must iron deficiency trigger a search for its cause?
Iron deficiency results when intake or absorption cannot meet demand, or when iron is lost through bleeding. Replacement addresses the shortage but does not necessarily remove the mechanism producing it. The history should examine menstrual and gastrointestinal blood loss, diet, increased requirements, and conditions affecting absorption. The likely cause changes with age and clinical context. Persistent or recurrent deficiency after replacement is a signal to reconsider ongoing loss, impaired absorption, or an incomplete explanation.
Apply it
An adult with iron-deficiency anemia has no clear dietary restriction but reports dark stools. Investigate possible gastrointestinal blood loss while addressing the iron deficit, rather than treating replacement as sufficient explanation and management of the problem.
Common pitfall: Attributing every deficiency to diet can miss ongoing bleeding or malabsorption. Improvement with iron demonstrates response to replacement, not proof that the cause has resolved.
Infectious Diseases7%
32.How do timing and the testing sequence affect Lyme serology?
Lyme serology detects antibodies that take time to develop, so early infection can produce a negative result. Interpret testing with symptom timing, exposure likelihood, and compatible findings, particularly a characteristic expanding erythema migrans lesion. CDC recommends two-step serology: a positive or equivocal initial assay requires the second assay for the complete interpretation. An isolated positive screen does not establish a completed positive algorithm, and a negative early test does not automatically override a compelling clinical presentation.
Apply it
A patient has a characteristic expanding lesion shortly after likely tick exposure but negative early serology. Account for delayed antibody development. If an initial assay is positive or equivocal, obtain the required second-step result rather than diagnosing from the screen alone.
Common pitfall: Early negative testing and incomplete positive testing have different limitations. Neither justifies ignoring clinical probability or diagnosing Lyme disease from nonspecific symptoms alone.
33.When should suspected influenza receive prompt antiviral treatment?
Start influenza antiviral treatment promptly for suspected or confirmed infection in hospitalized patients, patients with severe or progressive illness, and those at higher risk of complications. Do not delay treatment in these priority groups while awaiting influenza test results. Benefit is greatest when treatment begins within 48 hours, but later treatment can still benefit severe, hospitalized, or high-risk patients. Oral or enteric oseltamivir is recommended for hospitalized patients. See [CDC antiviral guidance](https://www.cdc.gov/flu/hcp/antivirals/summary-clinicians.html).
Apply it
A hospitalized patient has suspected influenza after three days of symptoms. Begin appropriate antiviral treatment promptly while obtaining diagnostic testing; the elapsed 48-hour interval is not a reason to withhold treatment.
Common pitfall: The early-treatment window for uncomplicated illness is not an absolute cutoff for severe or high-risk disease. Waiting for laboratory confirmation can delay indicated treatment.
34.Why are Lyme antibodies unsuitable as a test of cure?
Antibodies generated during Lyme infection may remain detectable for months or years after the infection has resolved. Their persistence reflects immune memory, not necessarily ongoing viable infection. Repeating serology to prove cure can therefore create confusion and unnecessary treatment. Assess the clinical course and investigate persistent symptoms on their merits. A positive result in someone with previous infection must be interpreted with current symptoms and exposure history rather than assumed to represent relapse.
Apply it
A patient who completed treatment and recovered remains seropositive during later testing. Explain that persistent antibodies can outlast infection and do not independently establish treatment failure or a need for another antibiotic course.
Common pitfall: Seropositivity does not measure bacterial burden. Repeatedly treating the antibody result can obscure other explanations for symptoms and does not provide a meaningful cure assessment.
35.When can Lyme serology produce misleading positive results?
Lyme antibody tests can cross-react with other conditions, so a positive result is less persuasive when exposure likelihood and clinical compatibility are low. Timing also matters: CDC advises disregarding positive IgM results when illness has lasted more than 30 days. This boundary helps avoid interpreting a late isolated IgM signal as evidence of active infection. Use the complete testing algorithm and clinical probability rather than allowing any positive antibody component to determine the diagnosis.
Apply it
A patient has several months of nonspecific fatigue, no plausible tick exposure, and an isolated positive Lyme IgM report. Reconsider the timing and clinical probability instead of diagnosing active Lyme disease from that result alone.
Common pitfall: A positive assay is not independent of pretest probability. Late isolated IgM results and cross-reactivity can create convincing-looking evidence that does not establish active Lyme infection.
Musculoskeletal System8%
36.Which investigation is central to suspected septic arthritis?
Suspected native-joint septic arthritis requires prompt aspiration for synovial-fluid assessment, particularly bacterial identification by culture. Fluid analysis also includes cell count, differential, Gram stain, and crystals as appropriate. A positive Gram stain provides useful early evidence, but its limited sensitivity means a negative stain does not exclude infection. Serum inflammatory markers cannot substitute for joint sampling. A painful swollen joint with restricted movement warrants urgent consideration even without fever or striking systemic inflammation.
Apply it
A patient has an acutely swollen, painful knee with marked movement restriction. Arrange prompt arthrocentesis and bacterial culture. Maintain concern when preliminary Gram stain shows no organisms, because the result does not establish a sterile joint.
Common pitfall: Blood tests and negative preliminary microscopy cannot replace synovial culture. No organisms seen is not equivalent to no infection present.
Guideline for Management of Septic Arthritis in Native Joints (SANJO)
37.How should crystals and synovial white-cell counts affect infection assessment?
Crystals can explain an inflammatory arthritis attack, but crystal disease and bacterial infection can coexist. A synovial white-cell count above 50,000 cells/µL suggests septic arthritis without proving it; a count below 25,000 cells/µL reduces probability without excluding infection. Counts overlap with crystal arthritis, and usual thresholds may be less reliable in immunosuppressed patients. Continue bacterial culture when infection remains plausible rather than using crystals or a numerical boundary to close the differential.
Apply it
A febrile patient has urate crystals and 32,000 synovial white cells/µL. Continue microbiologic assessment. An immunosuppressed patient with a count of 18,000 cells/µL also cannot be cleared of infection solely by that lower count.
Common pitfall: Crystals and inflammatory counts change probabilities; they are not universal infection exclusions. A convincing noninfectious mechanism can coexist with septic arthritis.
Guideline for Management of Septic Arthritis in Native Joints (SANJO)
38.How does gout assessment distinguish crystal deposition from hyperuricemia?
Gout results from urate crystal deposition that provokes joint inflammation. Elevated serum urate increases susceptibility, but many people with hyperuricemia do not develop gout. Assess the joint presentation and, when needed, identify urate crystals in aspirated joint fluid using microscopy; ultrasound or specialised CT can demonstrate crystal deposits. Treating an acute flare with anti-inflammatory therapy and lowering urate to prevent future deposition address different objectives. See [NIAMS gout overview](https://www.niams.nih.gov/health-topics/gout) and [diagnosis and treatment](https://www.niams.nih.gov/health-topics/gout/diagnosis-treatment-and-steps-to-take).
Apply it
A patient has a painful swollen joint and elevated serum urate. Evaluate the clinical pattern and obtain crystal assessment when needed rather than diagnosing gout from the blood value alone. Continue culture if infection is plausible.
Common pitfall: Hyperuricemia alone does not establish gout, and relieving the current flare does not necessarily prevent subsequent crystal deposition or recurrent attacks.
PANRE-PANRELA-2023CB20230224.pdf · Guideline for Management of Septic Arthritis in Native Joints (SANJO)
39.Which findings suggest acute compartment syndrome after limb injury?
Bleeding or swelling within a fascial compartment raises pressure and disrupts perfusion of muscles and nerves. Severe pain out of proportion to the injury, pain with stretching the involved muscles, and a tight or full compartment raise concern for acute compartment syndrome. Paresthesia may occur; numbness and paralysis are late findings. This requires immediate emergency surgical assessment, with compartment-pressure measurement when needed and fasciotomy to relieve confirmed acute disease. See [AAOS compartment syndrome information](https://www.orthoinfo.org/diseases--conditions/compartment-syndrome/).
Apply it
After a fracture, a patient develops escalating pain, a tense compartment, and pronounced pain when the affected muscles are stretched. Arrange immediate assessment for compartment syndrome rather than waiting for paralysis.
Common pitfall: Waiting for late neurologic loss risks permanent injury. Acute post-injury compartment syndrome differs from exertional symptoms that resolve when exercise stops.
40.When should antibiotics follow or precede joint sampling?
In a stable patient with suspected septic arthritis, obtain synovial fluid and relevant blood cultures before starting empirical antibiotics when feasible, because prior therapy can reduce microbiologic yield. This sequencing must not delay urgent treatment in sepsis or septic shock. The discriminating decision is physiological stability, not a rigid sampling rule. Organise aspiration promptly so diagnostic quality and timely treatment reinforce each other rather than becoming competing excuses for delay.
Apply it
A stable patient has a suspected infected knee and aspiration can be performed immediately. Obtain fluid and indicated blood cultures before empirical antibiotics. If shock develops, initiate urgent sepsis treatment without waiting for the procedure.
Common pitfall: Waiting for aspiration in septic shock misapplies a diagnostic-quality principle. Giving antibiotics before readily available sampling in a stable patient can unnecessarily reduce culture yield.
Guideline for Management of Septic Arthritis in Native Joints (SANJO)
Neurologic System5%
41.Why is urgent brain imaging necessary in suspected stroke?
Acute focal neurologic symptoms can arise from ischemic stroke or intracranial bleeding, and their treatments differ. Urgent brain imaging identifies hemorrhage and contributes to assessment of ischemia and other causes. Noncontrast CT is commonly used rapidly; MRI may supply additional information in selected settings. Clinical findings alone do not safely determine stroke type. A normal early scan also does not automatically exclude ischemic stroke, so imaging must be interpreted with the examination and symptom timeline.
Apply it
A patient develops abrupt unilateral weakness and speech difficulty. Activate urgent stroke assessment and obtain brain imaging to distinguish bleeding from ischemia rather than choosing a stroke-specific treatment from the symptom pattern alone.
Common pitfall: Focal deficits do not uniquely identify ischemia. Conversely, early imaging without a visible infarct does not by itself justify dismissing a clinically suspected ischemic stroke.
42.How does glucose testing help evaluate a stroke-like presentation?
Abnormal blood glucose, especially hypoglycemia, can produce neurologic dysfunction that resembles stroke. Rapid glucose measurement identifies a treatable contributor or mimic during the initial assessment. Correcting a low glucose result and reassessing the examination helps determine whether deficits resolve, but glucose testing does not replace urgent brain imaging when stroke remains possible. The principle is parallel evaluation: identify reversible metabolic problems while continuing assessment of a potentially time-critical vascular event.
Apply it
A patient with sudden confusion and unilateral weakness has a very low bedside glucose. Correct the hypoglycemia promptly and reassess the deficits while maintaining the appropriate stroke evaluation if focal abnormalities persist or concern remains.
Common pitfall: A metabolic abnormality can coexist with stroke. Finding low glucose should trigger correction and reassessment, not automatic cancellation of all further neurologic evaluation.
43.How do the stroke timeline and imaging guide reperfusion treatment?
Last known well is the latest time the patient was known to be at neurologic baseline; discovery time can be later. Document both accurately. After hemorrhage exclusion and eligibility assessment, adults with disabling ischemic deficits within 4.5 hours may receive IV alteplase or tenecteplase; treatment should begin rapidly without waiting for unnecessary advanced imaging. Selected patients with unknown onset or later presentation may qualify through advanced imaging showing a suitable mismatch. A demonstrated large-vessel occlusion prompts thrombectomy assessment, including selected patients up to 24 hours. These are distinct selection pathways, not permission to treat every deficit identically. See the [2026 AHA/ASA guideline](https://www.ahajournals.org/doi/10.1161/STR.0000000000000513).
Apply it
Disabling aphasia began two hours ago and CT excludes hemorrhage. Assess IV thrombolysis eligibility promptly. For deficits discovered on awakening, retain the true last-known-well time and assess imaging-based options rather than substituting discovery time or automatically excluding reperfusion.
Common pitfall: Time alone does not establish eligibility. A low NIHSS score can accompany a disabling deficit; conversely, mild nondisabling deficits have a different treatment pathway.
Psychiatry/Behavioral Science7%
44.How are mania and hypomania distinguished?
Both require abnormal elevated, expansive, or irritable mood plus increased activity or energy, present most of the day nearly every day. At least three associated symptoms are required, or four when mood is only irritable: grandiosity, reduced sleep need, increased speech, racing thoughts, distractibility, increased goal-directed activity or psychomotor agitation, and risky activity. Mania lasts at least seven days, or any duration when hospitalization is necessary, and causes marked impairment, necessitates hospitalization, or includes psychosis. Hypomania lasts at least four consecutive days, with an observable change from baseline but no marked impairment, hospitalization, or psychosis. Psychosis excludes hypomania. Exclude substance, medication, and medical causes. See the [DSM criteria comparison](https://www.ncbi.nlm.nih.gov/books/NBK519704/table/ch3.t9/).
Apply it
A patient has abnormal elevated mood and increased energy with reduced sleep need, pressured speech, and reckless spending. Establish duration, change from baseline, associated symptoms, impairment, hospitalization need, psychosis, and alternative causes before classifying the episode.
Common pitfall: Energy or reduced sleep alone does not establish an episode. Hospitalization necessary for mania removes the seven-day minimum; psychosis prevents classification as hypomania.
NIMH: Bipolar Disorder · Psychiatry.org - What Are Bipolar Disorders?
45.What history distinguishes bipolar II disorder from unipolar depression?
Bipolar II disorder requires a history of major depression and hypomania, without a manic episode. Patients often seek help during depression and may not volunteer prior periods of increased energy because those periods felt productive or pleasurable. Ask specifically about abnormal elevated or irritable mood accompanying increased energy, reduced need for sleep, and observable changes in activity, speech, and risk-taking. Establish duration, departure from baseline, consequences, and possible medication, substance, or medical causes. A current depressive episode alone cannot establish whether the illness is unipolar or bipolar.
Apply it
A patient presenting with depression recalls several days of unusually elevated mood, high energy, little sleep without fatigue, and conspicuous increased activity. Clarify whether that period met hypomanic criteria and whether any lifetime manic episode occurred.
Common pitfall: Diagnosing solely from the current depressive state can miss bipolar II disorder. Past periods of apparent productivity may be clinically relevant when they represent hypomania.
Psychiatry.org - What Are Bipolar Disorders? · NIMH: Bipolar Disorder
46.Why can antidepressant monotherapy destabilise bipolar illness?
In bipolar disorder, treatment must account for vulnerability to elevated as well as depressed mood states. Antidepressants used without an appropriate bipolar treatment strategy can precipitate mania or hypomania or otherwise destabilise mood. A history of elevated-energy episodes should therefore be explored before treating apparent unipolar depression. Mood-stabilising treatments and selected antipsychotics have central roles, with the regimen tailored to the episode and patient. Antidepressant use requires careful indication and monitoring.
Apply it
A depressed patient reports a previous episode of markedly increased energy and reckless spending after starting an antidepressant. Reassess the mood history and treatment plan for bipolar illness before simply restarting antidepressant monotherapy at a higher intensity.
Common pitfall: A depressive presentation does not guarantee a unipolar disorder. Ignoring previous activation or hypomania can lead to a treatment choice that worsens mood instability.
NIMH: Bipolar Disorder · Psychiatry.org - What Are Bipolar Disorders?
47.What establishes a major depressive episode, and when does it support major depressive disorder?
A major depressive episode requires at least five symptoms during the same two-week period, including depressed mood or loss of interest or pleasure, with a change from baseline and clinically significant distress or impairment. Other symptoms include appetite or weight change, sleep change, psychomotor change, fatigue, worthlessness or excessive guilt, impaired concentration, and recurrent thoughts of death or suicide. Assess substance, medication, medical, and psychotic-disorder explanations. Major depressive disorder also requires absence of a qualifying manic or hypomanic history; the same depressive episode can occur in bipolar illness. See [diagnostic criteria for MDD](https://www.ncbi.nlm.nih.gov/books/NBK571021/box/ch4.b4/).
Apply it
An adult has three weeks of depressed mood, loss of interest, insomnia, fatigue, poor concentration, and impaired work performance. Assess alternative causes, prior elevated-mood episodes, and suicidal thinking before determining the longitudinal diagnosis.
Common pitfall: Sadness alone does not establish a major depressive episode. Meeting depressive-episode criteria does not distinguish unipolar from bipolar illness without the lifetime mood history.
PANRE-PANRELA-2023CB20230224.pdf · Psychiatry.org - What Are Bipolar Disorders?
Pulmonary System10%
48.How does bronchodilator testing support asthma diagnosis?
Asthma produces variable expiratory airflow limitation. In an adult with compatible respiratory symptoms, GINA's positive bronchodilator-response criterion includes an FEV1 increase of at least 12% and at least 200 mL from the pre-bronchodilator baseline. An increase from 2.00 L to 2.40 L is 400 mL and 20%, meeting both thresholds. This supports variable airflow limitation within the asthma diagnostic assessment; it does not independently establish the entire diagnosis. A single negative test may be nondiagnostic between symptoms or during treatment.
Apply it
An adult with recurrent wheeze has FEV1 rising from 2.00 L to 2.40 L after bronchodilator. Calculate 0.40/2.00 × 100 = 20% and an absolute increase of 400 mL. Both satisfy the stated adult response thresholds.
Common pitfall: Use the pretreatment value as the percentage denominator and assess both the relative and absolute thresholds. A positive response must still be interpreted with symptoms and competing diagnoses.
49.When does normal spirometry fail to exclude asthma?
Asthma's airflow limitation can vary over time, so spirometry may be normal when symptoms are absent. If the history remains compatible, repeat testing during symptoms or consider appropriate bronchial challenge testing to demonstrate airway hyperresponsiveness. The next test should address the unresolved variability rather than treating one normal measurement as permanent proof against asthma. Alternative causes of cough or breathlessness also remain relevant, especially when repeated objective assessments do not support the suspected mechanism.
Apply it
A patient reports recurrent nocturnal wheeze, but spirometry is normal on a symptom-free morning. Seek objective evidence through appropriately timed repeat testing or bronchial challenge rather than excluding asthma from that single normal session.
Common pitfall: Normal testing between episodes can miss variable disease. The opposite error is retaining an asthma label indefinitely despite incompatible symptoms and repeatedly unsupported objective findings.
50.Why is anti-inflammatory treatment central to adult asthma care?
Asthma includes airway inflammation as well as bronchoconstriction. A bronchodilator can relieve tightening without adequately treating the inflammatory process that contributes to exacerbation risk. GINA therefore recommends ICS-containing treatment for adults and adolescents, with the regimen chosen according to clinical needs. Its preferred track uses ICS-formoterol as the reliever; higher steps may combine maintenance and reliever use. Formoterol-containing regimens have specific roles and should not be generalised to every ICS-LABA product.
Apply it
An adult with confirmed asthma relies only on a rescue bronchodilator. Review an appropriate ICS-containing strategy that addresses inflammation and exacerbation risk, then explain the selected maintenance and reliever roles clearly for the particular inhaler regimen.
Common pitfall: Symptom relief does not equal inflammatory control. Also, different ICS-LABA combinations are not automatically interchangeable as relievers; the selected regimen must match supported use.
51.How is difficult-to-treat asthma distinguished from severe asthma?
Poor asthma control can reflect incorrect inhaler technique, poor adherence, ongoing exposures, comorbidities, or an incorrect diagnosis. These modifiable explanations should be assessed before assuming intrinsic treatment resistance. Severe asthma is a subset that remains uncontrolled despite adherence to optimised high-dose ICS-LABA treatment and management of contributing factors, or worsens when that treatment is reduced. The distinction matters because escalation without correcting delivery or diagnosis may add medication while leaving the actual cause of poor control unchanged.
Apply it
A patient reports persistent symptoms despite prescribed controller therapy but demonstrates incorrect inhaler use. Correct technique and reassess adherence, diagnosis, and contributing factors before labelling the illness severe or escalating directly to specialised add-on treatment.
Common pitfall: A high prescribed dose does not prove that effective treatment reached the airways. Poor technique or adherence can imitate treatment resistance and distort severity classification.
52.Which imaging tests investigate pulmonary embolism?
CT pulmonary angiography visualises pulmonary arteries using contrast and is commonly used to investigate pulmonary embolism. Ventilation/perfusion imaging evaluates the relationship between air movement and blood flow and can be useful when CT contrast is unsuitable. Choice depends on the patient's circumstances and the diagnostic pathway. A chest radiograph may investigate alternative causes and inform imaging interpretation, but it does not directly exclude pulmonary embolism. Match imaging to the suspected vascular obstruction and relevant contraindications.
Apply it
A stable patient requires pulmonary embolism imaging but has a major contraindication to iodinated contrast. Consider ventilation/perfusion imaging within the appropriate diagnostic pathway rather than assuming that inability to undergo CTPA ends the investigation.
Common pitfall: A normal chest radiograph does not exclude pulmonary embolism. Different chest imaging modalities answer different questions and should not be substituted without considering their diagnostic purpose.
53.Why must D-dimer be interpreted with pulmonary embolism probability?
D-dimer reflects fibrin breakdown and can rise in many conditions besides venous thromboembolism. A positive result therefore does not confirm pulmonary embolism. In an appropriate low-probability diagnostic pathway, a negative result can help exclude disease, whereas high clinical suspicion generally requires definitive evaluation rather than reliance on a nonspecific blood test. The useful sequence is to assess clinical probability first, then choose testing that can meaningfully change the decision.
Apply it
A patient with recent surgery has a positive D-dimer and new breathlessness. Recognise that surgery can elevate D-dimer, so use the full clinical probability and appropriate imaging pathway rather than treating the blood result as diagnostic.
Common pitfall: A positive D-dimer is not a clot image. Ordering it without considering probability can create avoidable ambiguity, especially when other conditions predictably elevate the result.
Renal System4%
54.When does reduced kidney function qualify as CKD?
CKD requires abnormalities of kidney structure or function present for at least three months with implications for health. Reduced eGFR can meet a functional criterion when persistent, but one abnormal result during acute illness does not establish chronicity. Prior measurements, imaging, history, and repeat testing help distinguish chronic disease from acute injury. Persistently reduced eGFR below 60 mL/min/1.73 m² is important, while higher values require other markers of kidney damage to establish CKD.
Apply it
A dehydrated patient has a first recorded eGFR of 48 mL/min/1.73 m². Evaluate the acute illness and review prior kidney data, then establish persistence or other chronic evidence before assigning a definitive CKD diagnosis.
Common pitfall: A single low eGFR is not proof of chronic disease. Conversely, preserved eGFR does not exclude CKD when persistent structural or other kidney-damage markers are present.
55.How do confirmed albuminuria and GFR jointly classify CKD?
KDIGO classifies CKD by cause, GFR category, and albuminuria category, abbreviated CGA. An eGFR of 45–59 mL/min/1.73 m² is G3a; urine ACR of 30–300 mg/g is A2, and above 300 mg/g is A3. Patients with the same eGFR can have different risks when albuminuria differs. Confirm elevated random ACR with a subsequent first-morning midstream sample, considering exercise, infection, and blood contamination. Confirm positive dipstick findings quantitatively. Measurement confirmation and evidence of chronic persistence are separate requirements.
Apply it
A patient has chronic eGFR of 52 mL/min/1.73 m² and first-morning ACR of 180 mg/g confirming an elevated random result. Classify the measurements as G3a and A2 and retain the cause in the overall description. After exercise-associated isolated albuminuria, establish persistence before diagnosing CKD.
Common pitfall: Reporting filtration alone loses risk information. Quantifying one abnormal urine sample does not establish chronicity, and transient influences can cause premature classification.
KDIGO-2024-CKD-Guideline.pdf · Executive Summary of the KDIGO 2024 CKD Guideline
56.How should kidney-protective ACE inhibitor or ARB treatment be selected and monitored?
KDIGO recommends an ACE inhibitor or ARB for diabetic CKD G1–G4 with A2 or A3 albuminuria, and for nondiabetic CKD with A3; it suggests this treatment for nondiabetic A2 disease. Avoid combining ACE inhibitors and ARBs. Check blood pressure, creatinine, and potassium within 2–4 weeks after initiation or dose increases. A creatinine rise greater than 30% within four weeks requires evaluation and treatment review. Symptomatic hypotension or hyperkalemia uncontrolled despite treatment can require dose reduction or discontinuation; manageable hyperkalemia does not automatically require stopping therapy.
Apply it
Start an appropriate ACE inhibitor or ARB for diabetic CKD with confirmed A2 albuminuria. Arrange laboratory and blood-pressure review within 2–4 weeks. If creatinine rises 35%, investigate and reconsider treatment rather than continuing unchanged.
Common pitfall: Kidney protection requires safety monitoring. Combining ACE inhibitors and ARBs adds risk, and a substantial creatinine rise should not be dismissed as routine.
KDIGO-2024-CKD-Guideline.pdf · PANRE-PANRELA-2023CB20230224.pdf
Reproductive System5%
57.What does pregnancy of unknown location mean?
Pregnancy of unknown location describes a positive pregnancy test when ultrasound has not identified an intrauterine or extrauterine pregnancy. It is a temporary classification, not a final diagnosis of ectopic pregnancy or miscarriage. Possibilities include an early intrauterine pregnancy, a failing pregnancy, or an ectopic pregnancy. Follow-up with clinical assessment, serial pregnancy-hormone measurements, and repeat imaging resolves the uncertainty. Symptoms and stability determine urgency throughout follow-up rather than the label alone.
Apply it
A stable patient has a positive pregnancy test but no pregnancy identified on transvaginal ultrasound. Explain the possible outcomes and arrange continued location assessment, with explicit instructions to seek urgent care if concerning symptoms develop.
Common pitfall: An empty uterus on one early scan does not independently prove ectopic pregnancy. The unknown-location label requires continued assessment until the situation is resolved.
RCOG: Ectopic Pregnancy · Royal Free London: Pregnancy of Unknown Location
58.Why does rising hCG fail to establish pregnancy location?
Serial hCG measurements describe pregnancy-hormone activity but do not directly show where the pregnancy is implanted. Even a rise that appears reassuring, including doubling, cannot independently exclude an ectopic pregnancy. In a pregnancy of unknown location, use the trend to guide follow-up alongside symptoms and repeat ultrasound. The discriminating principle is biochemical change versus anatomical confirmation: increasing hormone levels may justify continued assessment, but they do not transform an unlocated pregnancy into a confirmed intrauterine pregnancy.
Apply it
A stable patient's hCG approximately doubles, but the pregnancy has not been located by ultrasound. Continue planned location follow-up and repeat imaging rather than announcing that the hormone pattern has proved a normal intrauterine pregnancy.
Common pitfall: A reassuring biochemical trend is not an anatomical diagnosis. Ending follow-up because hCG rises appropriately can miss an ectopic pregnancy that remains unlocated.
NNUH: Diagnosis and Management of Ectopic Pregnancy and Pregnancy of Unknown Location · Royal Free London: Pregnancy of Unknown Location
59.Which symptoms suggest bleeding from an ectopic pregnancy?
An ectopic pregnancy can rupture and cause internal bleeding. Severe abdominal pain, shoulder-tip pain, fainting, or circulatory compromise in a pregnant patient raises urgent concern. Shoulder-tip pain can reflect irritation associated with blood in the abdomen, and little external vaginal bleeding does not exclude substantial internal loss. In an unstable patient, emergency assessment and management take priority over routine serial-hCG follow-up. Previous reassuring results do not cancel a new dangerous clinical change.
Apply it
A patient undergoing unknown-location follow-up develops severe pain, shoulder-tip discomfort, and faintness with hypotension. Arrange immediate emergency care for possible internal bleeding rather than waiting for the next scheduled hormone measurement or ultrasound appointment.
Common pitfall: The amount of vaginal bleeding does not reliably measure internal hemorrhage. New instability overrides a previously reassuring trend or an existing outpatient follow-up plan.
Emergent Topics (Legal, Ethical, DEI)2%
60.Which abilities establish decision-making capacity, and what limits emergency consent?
Assess four abilities: understanding relevant information, appreciating its application and consequences for one's own situation, reasoning about alternatives, and communicating a choice. Explain the diagnosis, intervention, benefits, material risks, alternatives, and consequences of refusal; assess voluntariness and document the decision. A signature or accurate recitation alone is insufficient, and disagreement does not establish incapacity. Urgently necessary treatment may proceed when the patient cannot participate and no surrogate or applicable advance directive is available to guide decisions. Known applicable refusals remain relevant. Notify the patient or surrogate promptly and obtain consent for ongoing care. See [AMA capacity assessment](https://journalofethics.ama-assn.org/article/influence-psychiatric-symptoms-decisional-capacity-treatment-refusal/2017-05) and [advance-directive guidance](https://code-medical-ethics.ama-assn.org/ethics-opinions/advance-directives).
Apply it
A patient accurately repeats that untreated illness can be fatal but insists, because of a fixed delusion, that the diagnosed illness cannot affect them. Understanding may be intact while appreciation is impaired. Another patient who appreciates personal risks and compares alternatives may capably refuse recommended care.
Common pitfall: Recitation does not establish appreciation or reasoning. Incapacity does not erase known applicable treatment preferences, and emergency authority does not create blanket consent for continuing care.
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Use the complete January 2023 NCCPA outline to identify topics beyond this selective guide; preserve the published emphasis on cardiovascular, pulmonary, and gastrointestinal knowledge.
- Map each selected disease to its official performance expectations. For hypothyroidism, diabetes, CKD, and stroke, practise treatment, monitoring, complications, and escalation alongside presentation and diagnosis.
- Practise separating clinical suspicion from diagnostic confirmation: irregular pulse versus ECG, celiac susceptibility versus active disease, and rising hCG versus pregnancy location.
- Recognise immediate threats in acute scrotal pain, focal neurologic deficits, compromised circulation with pericardial effusion, painful visual loss, compartment syndrome, and possible ectopic hemorrhage.
- Interpret tests in context: early Lyme serology, synovial Gram stain, interval spirometry, risk-based pediatric imaging, and inflammation-sensitive ferritin each have important boundaries.
- Use longitudinal data to adjust care: thyroid replacement reassessment, individual glycemic targets, CKD chronicity and albuminuria, and creatinine and potassium monitoring after kidney-protective treatment.
- Build treatment decisions around mechanisms: drainage for an abscess, repositioning for BPPV, anti-inflammatory asthma care, timely influenza antivirals, and reperfusion selection in ischemic stroke.
- Assess understanding, appreciation, reasoning, and communication separately when evaluating capacity, and incorporate applicable directives and known treatment preferences when a patient cannot participate.
A practical preparation plan
1. Map the full outline to your current practice gaps
Review every official domain and disease row. Mark unfamiliar topics, especially those outside your usual specialty, and use the issuer weights to allocate study time without omitting smaller domains. Record whether each row requires presentation, diagnosis, basic intervention, or complex intervention.
2. Turn each concept into a clinical decision
Before reading the answer, state the mechanism, decisive clue, next useful test or action, and finding that would change the decision. For intervention topics, add the treatment, monitoring interval, important adverse effect, and escalation trigger. Compare your reasoning with the application and pitfall.
3. Complete the questions before reading explanations
Choose one option and record the specific cue that supports it. For each missed or uncertain question, explain why the other three option texts fail in that clinical setting.
4. Revisit uncertainty with active recall
Use the flashcards to recall mechanisms and test limitations without looking at the back. Repeat difficult cards after a delay and rewrite weak explanations in your own clinical language.
5. Expand beyond the selected topics
Return to uncovered rows in the full NCCPA blueprint and study their presentation, diagnosis, management, and complications using appropriate clinical references. The 60 concepts provide a decision framework rather than complete examination coverage.
6. Compare emergency presentations and decision-changing findings
Compare acute painful visual loss, flashes with a field curtain, sudden testicular pain, focal neurologic deficits, a hot swollen joint, and pregnancy-related circulatory compromise. For each, explain the threatened structure, the immediate assessment, and how instability or a decisive finding changes testing or treatment.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- NCCPA Content Blueprint for PANRE and PANRE-LA
- NCCPA PANRE Longitudinal Assessment Fact Sheet
- National Commission on Certification of Physician Assistants Certification Testing
- NHLBI: Heart Inflammation—Pericarditis
- NHLBI: Heart Valve Diseases—Diagnosis
- NHLBI: Heart Valve Diseases—Types
- NHLBI: Atrial Fibrillation—Diagnosis
- NHLBI: Heart Tests
- IDSA Guidelines for Skin and Soft Tissue Infections
- NIDDK: Thyroid Tests
- NIDDK: Hypothyroidism
- NIDDK: Diabetes Tests and Diagnosis
- NIDDK: Diabetes and Prediabetes Tests
- AAO-HNSF: Frequently Asked Questions—Benign Paroxysmal Positional Vertigo
- NIDDK: Diagnosis of Celiac Disease
- NIDDK: Diagnosis of Appendicitis
- NHS: Testicle Pain
- NHLBI: Iron-Deficiency Anemia
- CDC: Testing and Diagnosis for Lyme Disease
- Guideline for Management of Septic Arthritis in Native Joints (SANJO)
- NHLBI: Stroke—Diagnosis
- NIMH: Bipolar Disorder
- NHLBI: Asthma—Diagnosis
- NHLBI: Venous Thromboembolism—Diagnosis
- Executive Summary of the KDIGO 2024 CKD Guideline
- RCOG: Ectopic Pregnancy
- Royal Free London: Pregnancy of Unknown Location
- NNUH: Diagnosis and Management of Ectopic Pregnancy and Pregnancy of Unknown Location
- AMA Code of Medical Ethics: Informed Consent
- GINA-2026-Strategy-Report-WMS.pdf
- GINA-2026-Strategy-Report-WMS.pdf
- KDIGO-2024-CKD-Guideline.pdf
- KDIGO-2024-CKD-Guideline.pdf
- Psychiatry.org - What Are Bipolar Disorders?
- PANRE-PANRELA-2023CB20230224.pdf
- The A1C Test & Diabetes - NIDDK
- Celiac Disease Tests - NIDDK
- Preview
- iron-deficiency-dx-qmat.pdf
- Psychiatry.org - What Are Bipolar Disorders?
- Glaucoma | National Eye Institute
- Glaucoma and Eye Pressure | National Eye Institute
- Retinal Detachment | National Eye Institute
- Gout: Diagnosis, Treatment, and Steps to Take
- Compartment Syndrome - OrthoInfo - AAOS
- GINA-Summary-Guide-2026-WEB-WMS.pdf
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.